Teva announces U.S. FDA approval of three-times-a-week COPAXONE® 40mg/mL
28 January 2014 | By Teva
Teva Pharmaceutical Industries Ltd. announced that the FDA has approved the Company’s supplemental new drug application for three-times-a-week COPAXONE® 40mg/mL...